US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

3.230 +0.010 (+0.31%)
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
From KORU Medical Systems
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Preview For KORU Medical Systems ↗
 
Via Benzinga
News headline image
Repro-Med Systems's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
A Preview Of Repro-Med Systems's Earnings ↗
 
Via Benzinga
News headline image
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase
From KORU Medical Systems
Via Business Wire
News headline image
Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026 ↗
B. 
Via Benzinga
News headline image
Repro-Med Systems Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗
 
Via Benzinga
News headline image
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 8, 2023 ↗
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
News headline image
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
From KORU Medical Systems, Inc.
Via Business Wire
News headline image
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference
From KORU Medical Systems
Via Business Wire
News headline image
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 ↗
Upgrades 
Via Benzinga
News headline image
KORU Medical Systems Announces 2022 Third Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >